Copyright
©The Author(s) 2023.
World J Gastroenterol. Oct 7, 2023; 29(37): 5327-5338
Published online Oct 7, 2023. doi: 10.3748/wjg.v29.i37.5327
Published online Oct 7, 2023. doi: 10.3748/wjg.v29.i37.5327
Figure 6 Adverse events with semaglutide.
A: Gastrointestinal related side effects; B: Serious adverse events. 95%CI: 95% confidence intervals.
- Citation: Zhu K, Kakkar R, Chahal D, Yoshida EM, Hussaini T. Efficacy and safety of semaglutide in non-alcoholic fatty liver disease. World J Gastroenterol 2023; 29(37): 5327-5338
- URL: https://www.wjgnet.com/1007-9327/full/v29/i37/5327.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i37.5327